Brief: Silo Pharma Approves Extension Of Previously Announced Stock Repurchase Program
05/04/2024 22:31
April 5 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA INC: APPROVED EXTENSION OF PREVIOUSLY
ANNOUNCED
STOCK REPURCHASE PROGRAM AUTHORIZING PURCHASE OF UPTO $1.0
MILLION COMMON STOCK UNTIL APRIL 30
Source text for Eikon: ID:n0001213900-24-030805
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement